IMAGE

Fig. 5

ID
ZDB-IMAGE-210119-9
Source
Figures for El-Sahli et al., 2021
Image
Figure Caption

Fig. 5 Combination of verteporfin-NP, paclitaxel-NP, and combretastatin-NP decreased ex vivo viability of PDX organotypic slice culture.

A, B Ex vivo viability analysis (Almar blue assay) of PDX (HCI-001) organotypic slice culture after 120-hr treatment with E-NP (empty-NP), P-NP (paclitaxel-NP, 5 nM), V-NP (verteporfin-NP, 250 nM), C-NP (combretastatin-NP, 5 nM), or different combinations. Data represents means ± SEM, n = 3, *P < 0.05, **P < 0.01.

Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cell Death Dis.